Shop at The Natural Remedy for top shelf BC Buds
Low Dose THC may help prevent as well as treat Neurogenerative Diseases?
Neurodegenerative diseases are one of the leading causes of death and disability in Canada. Degenerative nerve diseases include Alzheimer’s, ALS, Huntingon’s Disease,Parkinson’s Disease to name a few… Currently, no neurodegenerative disease is curable, and the treatments available only manage the symptoms or halt the progression of the disease. Therefore, there is an urgent need for new treatments. Now there looks like there may be some hope… A study made at Tel-Aviv University in Israel looked into the effects of extremely-low dosages of THC in protecting the brain from inflammation-induced deficits. Alzheimer’s, Huntington’s, and Parkinson’s are some of the common neurodegenerative diseases. The researchers stated , “Our results suggest that an ultralow dose of TCH that lacks any psychotrophic activity protects the brain from neuroinflammation-induced cognitive damage and might be used as an effective treatment for neuroinflammatory conditions, including neurodegenerative diseases.”
Also, In 2014, researchers from the University of South Florida and Thomas Jefferson University collaborated on a study which revealed that THC contributes to the prevention of beta-amyloid plaque build-up in the brain. This plaque can cause nerve cell death and eventually, Alzheimer’s. THC also improves mitochondrial function. A cell’s mitochondria take nutrients which, after being broken down, is turned into energy. Studies have proven that mitochondrial dysfunction is one of the first signs of Alzheimer’s. To read full Natural News Article click here
A prior study conducted at UCSD’s Scripps Institute also found that THC was able to “block the aggression of plague completely”—and apparently more effectively than most known pharmaceutical drugs. This study also focused on THC’s effect on plaque-building proteins, but also how it fit in to the overall “cholinergic system,” a network of nerve cells and neurotransmitters often effected by Alzheimer’s disease progression. To read full article click here
Resources